Real-life Effectiveness of the Kaletra Adherence Support Assistance (KASA) Program

CompletedOBSERVATIONAL
Enrollment

173

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Human Immunodeficiency Virus Infection
Interventions
DRUG

Lopinavir / ritonavir

Prescribed according to the product monograph and physician's discretion.

BEHAVIORAL

Kaletra Adherence Support Assistance Program

A customized support network for patients treated with lopinavir / ritonavir that offers individual counseling with an HIV experienced nurse who assists patients with various aspects of their therapy including life-style changes, emotional stress, and adverse events, and may provide access to various healthcare professionals or may offer other types of support such as transportation, exercise, etc.

All Listed Sponsors
lead

AbbVie (prior sponsor, Abbott)

INDUSTRY

NCT01662336 - Real-life Effectiveness of the Kaletra Adherence Support Assistance (KASA) Program | Biotech Hunter | Biotech Hunter